Conor McNamara
Stock Analyst at RBC Capital
(0.77)
# 3,572
Out of 4,804 analysts
114
Total ratings
20.24%
Success rate
-22.22%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Outperform | $128 → $112 | $70.46 | +58.96% | 15 | Apr 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $7 → $4 | $1.84 | +117.98% | 3 | Mar 27, 2025 | |
| NTRA Natera | Initiates: Outperform | $251 | $133.04 | +88.67% | 1 | Mar 13, 2025 | |
| RGEN Repligen | Maintains: Outperform | $203 → $205 | $106.72 | +92.09% | 10 | Feb 21, 2025 | |
| QDEL QuidelOrtho | Maintains: Outperform | $64 → $61 | $25.51 | +139.12% | 11 | Feb 13, 2025 | |
| AVTR Avantor | Maintains: Outperform | $33 → $31 | $14.22 | +118.08% | 6 | Feb 10, 2025 | |
| HOLX Hologic | Maintains: Sector Perform | $88 → $85 | $58.24 | +45.96% | 9 | Feb 6, 2025 | |
| TECH Bio-Techne | Maintains: Sector Perform | $79 → $80 | $48.54 | +64.81% | 8 | Feb 6, 2025 | |
| DHR Danaher | Reiterates: Outperform | $299 → $277 | $174.32 | +58.91% | 8 | Jan 30, 2025 | |
| BIO Bio-Rad Laboratories | Reiterates: Outperform | $481 | $218.96 | +119.67% | 10 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $481 | $225.29 | +113.50% | 10 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $13 | $1.77 | +634.46% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $767 → $718 | $418.82 | +71.44% | 13 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $2.60 | +169.23% | 4 | Aug 7, 2024 |
Illumina
Apr 8, 2025
Maintains: Outperform
Price Target: $128 → $112
Current: $70.46
Upside: +58.96%
OmniAb
Mar 27, 2025
Maintains: Outperform
Price Target: $7 → $4
Current: $1.84
Upside: +117.98%
Natera
Mar 13, 2025
Initiates: Outperform
Price Target: $251
Current: $133.04
Upside: +88.67%
Repligen
Feb 21, 2025
Maintains: Outperform
Price Target: $203 → $205
Current: $106.72
Upside: +92.09%
QuidelOrtho
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $25.51
Upside: +139.12%
Avantor
Feb 10, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $14.22
Upside: +118.08%
Hologic
Feb 6, 2025
Maintains: Sector Perform
Price Target: $88 → $85
Current: $58.24
Upside: +45.96%
Bio-Techne
Feb 6, 2025
Maintains: Sector Perform
Price Target: $79 → $80
Current: $48.54
Upside: +64.81%
Danaher
Jan 30, 2025
Reiterates: Outperform
Price Target: $299 → $277
Current: $174.32
Upside: +58.91%
Bio-Rad Laboratories
Jan 14, 2025
Reiterates: Outperform
Price Target: $481
Current: $218.96
Upside: +119.67%
Jan 14, 2025
Reiterates: Outperform
Price Target: $481
Current: $225.29
Upside: +113.50%
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $1.77
Upside: +634.46%
Oct 24, 2024
Maintains: Outperform
Price Target: $767 → $718
Current: $418.82
Upside: +71.44%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $2.60
Upside: +169.23%